Abeona Therapeutics Inc. Insider Trading

ABEO

Last 12 months

Insiders sold $3.57M and bought nothing on the open market.

19% of the selling was scheduled in advance under 10b5-1 plans. Director Christine Berni Silverstein sold 104K on Jun 15, 13% of their stake, outside a plan. The last open-market buy by an executive or director was in May 2024.

Net open-market

−$3.57M

0 buys · 33 sales

Under a 10b5-1 plan

19%

of the value sold

Insiders who bought / sold

0 / 9

executives and directors

Last open-market buy

May 2024

May 16, 2024

Get an email when ABEO's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 29	Vishwas Seshadri Chief Executive Officer	SoldNo plan	19,608	$5.16	101K	1.5%	Form 4
Sep 29	Joseph Walter Vazzano Chief Financial Officer	SoldNo plan	9,191	$5.16	47K	1.9%	Form 4
Sep 29	Brendan M. O'Malley SVP, Chief Legal Officer	SoldNo plan	6,727	$5.16	35K	1.6%	Form 4
Sep 29	Madhav Vasanthavada Chief Commercial Officer	SoldNo plan	4,902	$5.16	25K	1.7%	Form 4
Sep 1	Mark Alvino Director	SoldNo plan	15,000	$5.86	88K	19%	Form 4
Jul 21	Joseph Walter Vazzano Chief Financial Officer	SoldNo plan	1,478	$6.53	10K	0.3%	Form 4
Jul 9	Joseph Walter Vazzano Chief Financial Officer	SoldNo plan	24,880	$6.96	173K	4.8%	Form 4
Jul 9	Vishwas Seshadri Chief Executive Officer	SoldNo plan	67,971	$6.96	473K	4.9%	Form 4
Jul 9	Brendan M. O'Malley SVP, Chief Legal Officer	SoldNo plan	12,050	$6.96	84K	2.7%	Form 4
Jul 9	Madhav Vasanthavada Chief Commercial Officer	SoldNo plan	12,606	$6.96	88K	4.2%	Form 4
Jun 30	Leila Alland Director	SoldNo plan	11,000	$5.92	65K	6.3%	Form 4
Jun 15	Christine Berni Silverstein Director	SoldNo plan	18,160	$5.71	104K	13%	Form 4
Jun 8 – 9	Joseph Walter Vazzano Chief Financial Officer	Sold10b5-1 plan 3 parts	49,338	$5.37 average	265K	8.7%	Form 4
Jun 8 – 9	Madhav Vasanthavada Chief Commercial Officer	SoldNo plan 2 parts	9,620	$5.36 average	52K	3.1%	Form 4
Jun 8 – 9	Vishwas Seshadri Chief Executive Officer	SoldNo plan 2 parts	56,344	$5.36 average	302K	3.9%	Form 4
Jun 8 – 9	Brendan M. O'Malley SVP, Chief Legal Officer	SoldNo plan 2 parts	11,131	$5.36 average	60K	2.5%	Form 4
May 22	Mark Alvino Director	SoldNo plan	6,500	$5.46	35K	7.7%	Form 4
May 15	Eric Crombez Director	Sold10b5-1 plan	26,143	$5.53	145K	41%	Form 4
May 11	Madhav Vasanthavada Chief Commercial Officer	SoldNo plan	5,548	$5.96	33K	1.7%	Form 4
Mar 31	Vishwas Seshadri Chief Executive Officer	Sold10b5-1 plan	29,985	$4.38	131K	2.1%	Form 4
Mar 16	Joseph Walter Vazzano Chief Financial Officer	SoldNo plan	785	$4.76	4K	0.1%	Form 4
Feb 2	Christine Berni Silverstein Director	SoldNo plan	20,070	$5.09	102K	13%	Form 4
Feb 2	Donald A. Wuchterl Director	SoldNo plan	14,814	$5.09	75K	8.1%	Form 4
Feb 2	Eric Crombez Director	SoldNo plan	16,284	$5.09	83K	20%	Form 4
Feb 2	Leila Alland Director	SoldNo plan	18,065	$5.09	92K	9.4%	Form 4
Feb 2	Mark Alvino Director	SoldNo plan	2,000	$5.09	10K	2.3%	Form 4
Jan 22	Madhav Vasanthavada Chief Commercial Officer	SoldNo plan	12,610	$5.29	67K	3.8%	Form 4
Jan 22	Joseph Walter Vazzano Chief Financial Officer	SoldNo plan	18,666	$5.33	99K	3.2%	Form 4
Jan 22	Vishwas Seshadri Chief Executive Officer	SoldNo plan	69,832	$5.33	372K	4.6%	Form 4
Jan 22	Brendan M. O'Malley SVP, Chief Legal Officer	SoldNo plan	13,578	$5.33	72K	2.9%	Form 4
Jan 21	Mark Alvino Director	SoldNo plan	13,500	$5.23	71K	22%	Form 4
Dec 29, 2025	Vishwas Seshadri Chief Executive Officer	Sold10b5-1 plan	25,000	$5.31	133K	2.1%	Form 4
Nov 13, 2025	Mark Alvino Director	SoldNo plan	15,000	$4.74	71K	19%	Form 4
Oct 16, 2025	Vishwas Seshadri Chief Executive Officer	SoldNo plan	249	$5.49	1K	<0.1%	Form 4
Sep 29, 2025 – Sep 30, 2025	Vishwas Seshadri Chief Executive Officer	Sold10b5-1 plan 2 parts	44,274	$5.31 average	235K	3.6%	Form 4
Sep 29, 2025	Brendan M. O'Malley SVP, Chief Legal Officer	SoldNo plan	9,366	$5.39	50K	2.6%	Form 4
Sep 29, 2025	Joseph Walter Vazzano Chief Financial Officer	SoldNo plan	9,035	$5.39	49K	2.0%	Form 4
Sep 22, 2025	Brendan M. O'Malley SVP, Chief Legal Officer	SoldNo plan	688	$5.43	4K	0.2%	Form 4
Aug 15, 2025	Joseph Walter Vazzano Chief Financial Officer	SoldNo plan	15,000	$7.36	110K	3.1%	Form 4
Aug 14, 2025	Eric Crombez Director	SoldNo plan	4,718	$6.93	33K	10%	Form 4

Sep 29No plan
Vishwas Seshadri
Chief Executive Officer · sold 19,608 at $5.16
101K
1.5% of stake
Sep 29No plan
Joseph Walter Vazzano
Chief Financial Officer · sold 9,191 at $5.16
47K
1.9% of stake
Sep 29No plan
Brendan M. O'Malley
SVP, Chief Legal Officer · sold 6,727 at $5.16
35K
1.6% of stake
Sep 29No plan
Madhav Vasanthavada
Chief Commercial Officer · sold 4,902 at $5.16
25K
1.7% of stake
Sep 1No plan
Mark Alvino
Director · sold 15,000 at $5.86
88K
19% of stake
Jul 21No plan
Joseph Walter Vazzano
Chief Financial Officer · sold 1,478 at $6.53
10K
0.3% of stake
Jul 9No plan
Joseph Walter Vazzano
Chief Financial Officer · sold 24,880 at $6.96
173K
4.8% of stake
Jul 9No plan
Vishwas Seshadri
Chief Executive Officer · sold 67,971 at $6.96
473K
4.9% of stake
Jul 9No plan
Brendan M. O'Malley
SVP, Chief Legal Officer · sold 12,050 at $6.96
84K
2.7% of stake
Jul 9No plan
Madhav Vasanthavada
Chief Commercial Officer · sold 12,606 at $6.96
88K
4.2% of stake
Jun 30No plan
Leila Alland
Director · sold 11,000 at $5.92
65K
6.3% of stake
Jun 15No plan
Christine Berni Silverstein
Director · sold 18,160 at $5.71
104K
13% of stake
Jun 8 – 910b5-1 plan
Joseph Walter Vazzano
Chief Financial Officer · sold 49,338 at avg $5.37
265K
8.7% of stake
Jun 8 – 9No plan
Madhav Vasanthavada
Chief Commercial Officer · sold 9,620 at avg $5.36
52K
3.1% of stake
Jun 8 – 9No plan
Vishwas Seshadri
Chief Executive Officer · sold 56,344 at avg $5.36
302K
3.9% of stake
Jun 8 – 9No plan
Brendan M. O'Malley
SVP, Chief Legal Officer · sold 11,131 at avg $5.36
60K
2.5% of stake
May 22No plan
Mark Alvino
Director · sold 6,500 at $5.46
35K
7.7% of stake
May 1510b5-1 plan
Eric Crombez
Director · sold 26,143 at $5.53
145K
41% of stake
May 11No plan
Madhav Vasanthavada
Chief Commercial Officer · sold 5,548 at $5.96
33K
1.7% of stake
Mar 3110b5-1 plan
Vishwas Seshadri
Chief Executive Officer · sold 29,985 at $4.38
131K
2.1% of stake
Mar 16No plan
Joseph Walter Vazzano
Chief Financial Officer · sold 785 at $4.76
4K
0.1% of stake
Feb 2No plan
Christine Berni Silverstein
Director · sold 20,070 at $5.09
102K
13% of stake
Feb 2No plan
Donald A. Wuchterl
Director · sold 14,814 at $5.09
75K
8.1% of stake
Feb 2No plan
Eric Crombez
Director · sold 16,284 at $5.09
83K
20% of stake
Feb 2No plan
Leila Alland
Director · sold 18,065 at $5.09
92K
9.4% of stake
Feb 2No plan
Mark Alvino
Director · sold 2,000 at $5.09
10K
2.3% of stake
Jan 22No plan
Madhav Vasanthavada
Chief Commercial Officer · sold 12,610 at $5.29
67K
3.8% of stake
Jan 22No plan
Joseph Walter Vazzano
Chief Financial Officer · sold 18,666 at $5.33
99K
3.2% of stake
Jan 22No plan
Vishwas Seshadri
Chief Executive Officer · sold 69,832 at $5.33
372K
4.6% of stake
Jan 22No plan
Brendan M. O'Malley
SVP, Chief Legal Officer · sold 13,578 at $5.33
72K
2.9% of stake
Jan 21No plan
Mark Alvino
Director · sold 13,500 at $5.23
71K
22% of stake
Dec 29, 202510b5-1 plan
Vishwas Seshadri
Chief Executive Officer · sold 25,000 at $5.31
133K
2.1% of stake
Nov 13, 2025No plan
Mark Alvino
Director · sold 15,000 at $4.74
71K
19% of stake
Oct 16, 2025No plan
Vishwas Seshadri
Chief Executive Officer · sold 249 at $5.49
1K
<0.1% of stake
Sep 29, 2025 – Sep 30, 202510b5-1 plan
Vishwas Seshadri
Chief Executive Officer · sold 44,274 at avg $5.31
235K
3.6% of stake
Sep 29, 2025No plan
Brendan M. O'Malley
SVP, Chief Legal Officer · sold 9,366 at $5.39
50K
2.6% of stake
Sep 29, 2025No plan
Joseph Walter Vazzano
Chief Financial Officer · sold 9,035 at $5.39
49K
2.0% of stake
Sep 22, 2025No plan
Brendan M. O'Malley
SVP, Chief Legal Officer · sold 688 at $5.43
4K
0.2% of stake
Aug 15, 2025No plan
Joseph Walter Vazzano
Chief Financial Officer · sold 15,000 at $7.36
110K
3.1% of stake
Aug 14, 2025No plan
Eric Crombez
Director · sold 4,718 at $6.93
33K
10% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ABEO, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ABEO

CompareIntrinsic value

PCYNProcyon Corporation

$0.18+0.00%20

HCWBHCW Biologics Inc.

$1.08-6.09%15

RANIRani Therapeutics Holdings Inc.

$0.57+3.02%10

BOLTBolt Biotherapeutics Inc.

$6.54-0.46%25

TRDAEntrada Therapeutics Inc.

$5.06+7.20%10

KZRKezar Life Sciences, Inc.

No recent price20

KYNBKyntra Bio, Inc.

$3.96-8.12%20

NAMSNewAmsterdam Pharma Co. N.V.

$20.93+5.18%10

Held by ETFs

ABEO is in 9 US ETFs. The largest of them, with ABEO's weight in each:

Spot a number that looks wrong? Check it in ABEO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ABEO

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.